Roche moves SC against Natco’s launch of generic Risdiplam in India

F. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a generic version of Risdiplam. Risdiplam treats spinal muscular atrophy. The High Court rejected Roche's plea to halt Natco's manufacturing. Natco plans to sell the drug at a significantly lower price.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7rRmOF1
via IFTTT